BWV News and Press, Blue Water Vaccines Inc. From 08/17/22

Gainers: Blue Water Vaccines ( BWV ) +108% . Hill International ( HIL ) +61% . Eargo ( EAR ) +58% . JE Cleantech Holdings ( JCSE ) +44% . Cassava Sciences ( SAVA ) +30% . Laird Superfood ( LSF ) +19% . LexinFintec...

Blue Water Vaccines Inc. (NASDAQ: BWV) reported that the company plans to explore potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.  The S&P platform is currently being utilized to develop vaccine...

Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....

U.S. vaccine maker Blue Water Vaccines ( NASDAQ: BWV ) on Wednesday said it plans to potentially develop a monkeypox shot using its technology, sending its shares surging 22.4% to $3.12 in premarket trading. Cincinnati, Ohio.-based BWV said it would develop the vaccine...

CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic about. However, bulli...

So far in 2022, IPO activity has been dominated by small, volatile issuers. Of the 19 IPOs with 100%+ pops, 17 have traded down from the first-day close, and 11 trade below issue. The 10 IPOs with the largest first-day pops each raised less than $50 million, with a median deal siz...

Blue Water Vaccines press release ( NASDAQ: BWV ): Q2 GAAP EPS of -$0.36. Cash was $22.2 million as of June 30, 2022 For further details see: Blue Water Vaccines GAAP EPS of -$0.36

Closed private placement in April 2022, with net proceeds of approximately $6.9 million Signed multiple strategic agreements and collaborations to further vaccine candidate research, development, and manufacturing $22.2 million in cash as of June 30, 2022 CINCINNATI, A...

CINCINNATI, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announc...